Two research groups have, to date, investigated the effects of Momordica charantia application to KB-V1 cervical cancer cells, which both focused on its regulatory capacities on the P-glycoprotein and the multidrug resistance phenotype [39,40]. Here, ABCB1 is linked to cervical carcinoma.